AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 69 filers reported holding AADI BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195,799 | -42.1% | 247,066 | -18.1% | 0.00% | – |
| Q2 2023 | $2,063,580 | -4.5% | 301,693 | +1.0% | 0.00% | – |
| Q1 2023 | $2,161,813 | -54.4% | 298,593 | -19.2% | 0.00% | -100.0% |
| Q4 2022 | $4,740,608 | -14.8% | 369,494 | -6.2% | 0.00% | 0.0% |
| Q3 2022 | $5,566,000 | +19.1% | 393,920 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $4,674,000 | -4.8% | 379,355 | +31.2% | 0.00% | 0.0% |
| Q1 2022 | $4,908,000 | -11.8% | 289,211 | +25.5% | 0.00% | 0.0% |
| Q4 2021 | $5,567,000 | +91.0% | 230,529 | +132.4% | 0.00% | 0.0% |
| Q3 2021 | $2,914,000 | – | 99,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $193,062 | 17.76% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,807,209 | 15.60% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $13,389,670 | 9.86% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,810,622 | 1.54% |
| Knott David M Jr | 183,688 | $1,330 | 0.52% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Ghost Tree Capital, LLC | 150,000 | $1,086,000 | 0.32% |
| Avoro Capital Advisors LLC | 2,849,402 | $20,629,670 | 0.31% |
| Parkman Healthcare Partners LLC | 75,961 | $549,958 | 0.12% |
| RA Capital Management | 590,218 | $4,273,178 | 0.10% |